Jun 01, 2020
CeloNova Announces Enrollment Completion of World's First Randomized Control, 14-Day DAPT Trial
May 20, 2020
COVID-19 Patients May Have Lower Stroke Rates Than Previously Suggested
May 12, 2020
ASH to Develop Clinical Practice Guidelines on the Use of Anticoagulation in Patients with COVID-19
May 08, 2020
PINNACLE FLX Study of the WATCHMAN FLX(TM) Left Atrial Appendage Closure Device Presented as Late-Breaking Clinical Trial at HRS 2020 SCIENCE
Mar 28, 2020
Landmark Phase 3 VOYAGER PAD Study of XARELTO® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization
Mar 17, 2020
Anticoagulants Market to Reach $43.42 Billion by 2025 at 7.5% CAGR: Allied Market Research
Feb 21, 2020
Anticoagulants Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2026
Feb 20, 2020
Anticoagulant Reversal Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2026
Feb 14, 2020
Firstkind to Showcase First New Approach to Prevent DVT in Immobile Stroke Patients in 20 Years at ISC 2020
Jan 03, 2020
UNC School of Medicine Expert Helps Treat Astronaut’s Blood Clot During NASA Mission
Dec 03, 2019
Visiongain Publishes Blood Preparation Market 2019-2029 Report
Nov 05, 2019
Global Anticoagulant Reversal Drugs Market Report 2019: Rise of AF in Aging Populations, Increase in the Prevalence of ICH and GI Hemorrhages, NTAP Status for Specific Drugs
Oct 28, 2019
United States Rodenticides Market Prospects, Trends Analysis, Market Size and Forecasts up to 2025 - ResearchAndMarkets.com
Oct 24, 2019
Fresenius Medical Care Receives FDA Breakthrough Device Designation for New Dialysis System to Prevent Blood Clotting Without the Use of Blood Thinners
Sep 26, 2019
Boston Scientific Announces Positive Data from the EVOLVE Short DAPT study with the SYNERGY(TM) Bioabsorbable Polymer Stent
Sep 20, 2019
XARELTO® (rivaroxaban) Reduces Recurrent Blood Clots and Total Medical Costs in Morbidly Obese Patients
Sep 03, 2019
New Study: Low-Intensity Warfarin Not as Effective as Conventional Warfarin to Prevent Clots after Joint Replacement
Aug 14, 2019
Heparin Market is Expected to Accumulate Revenues Worth US$16.3 Billion by 2025 - TMR
Jul 08, 2019
XARELTO® (rivaroxaban) Helps Protect Pediatric Patients from Blood Clots in Late-Breaking Phase 3 EINSTEIN-Jr Study
Jun 25, 2019
eXIthera Appoints Michael Kurz, Ph.D., to Leadership Team